Viewing Study NCT00001209



Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00001209
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03

Brief Title: A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Study Overview

Official Title: A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
Status: COMPLETED
Status Verified Date: 1999-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This protocol is designed to test the feasibility of the administration of vincristine adriamycin and cytoxan alternating with the newly developed regimen ifosfamide VP-16 as well as the efficacy of this therapy in addition to radiotherapy in producing complete responses and disease-free survival in patients with Ewings sarcoma primitive sarcoma of bone peripheral neuroepithelioma and soft tissue sarcoma This will not be a randomized study but will be comparable to the large data base of similar patients treated on successive Pediatric Branch studies
Detailed Description: This protocol is designed to test the feasibility of the administration of vincristine adriamycin and cytoxan alternating with the newly developed regimen ifosfamide VP-16 as well as the efficacy of this therapy in addition to radiotherapy in producing complete responses and disease-free survival in patients with Ewings sarcoma primitive sarcoma of bone peripheral neuroepithelioma and soft tissue sarcoma This will not be a randomized study but will be comparable to the large data base of similar patients treated on successive Pediatric Branch studies

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
86-C-0169 None None None